CDSCO panel gives Emcure Pharma waiver on Phase IV CT for Lamivudine plus Dolutegravir Dr. Divya Colin27 April 2022 6:19 PM ISTNew Delhi: Pharmaceutical major, Emcure Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under Central Drug...
Pharma Bribe to doctors: SC tells Centre to give detailed reply on stand on UCPMP status Ruchika Sharma26 April 2022 5:36 PM IST"This Code is enforceable against doctors, however, does not apply to drug companies, leading to anomalous situations where doctors' licenses are...
Dr. Reddy's gets CDSCO panel nod to study Fosravuconazole L Lysine Ethanolate Capsule Dr. Divya Colin25 April 2022 8:06 PM ISTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Novo Nordisk bags CDSCO panel nod to study anti neoplastic drug Concizumab Dr. Divya Colin24 April 2022 12:30 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's proposal for Phase IIIa clinical trial of antineoplastic drug Concizumab, the Subject Expert...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Dr. Divya Colin23 April 2022 5:03 PM ISTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
CoSara Diagnostics gets CDSCO clearance for Hepatitis C Viral Load Test Ruchika Sharma22 April 2022 11:00 AM ISTSalt Lake City: Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular...
Violation of Drugs Patents: Boehringer Ingelheim demands authorities set mechanisms in place Ruchika Sharma21 April 2022 3:42 PM ISTA notification system would be helpful if any manufacturer files for approval with a state government and the DCGI and the patent holder is notified...
Ahead of Linagliptin going off-patent, NPPA fixes retail price of its FDC with Metformin Susmita Roy20 April 2022 6:57 PM ISTNew Delhi: With the popular antidiabetic drug Linagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
NPPA fixes retail prices of 15 formulations, ceiling price of Framycetin Ruchika Sharma19 April 2022 4:06 PM ISTNew Delhi: National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 15...
Exemption to SII pneumococcal vaccine from price control for 5 years: NPPA Susmita Roy18 April 2022 5:49 PM ISTNew Delhi: In a major relief to Serum Institute of India, the drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has...
NPPA panel rejects Cadila Healthcare retail price fixation application for Tacrolimus PR capsules Susmita Roy17 April 2022 12:00 PM ISTNew Delhi: Citing that the Central Drugs Standard Control Organisation(CDSCO) has not given approval to Cadila Healthcare to import and manufacture...
Sun Pharma gets CDSCO committee approval for manufacturing Ranibizumab Susmita Roy16 April 2022 3:22 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
